Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

63.91 -1.78 (-2.70%)

Streaming Delayed Price Updated: 1:04 PM EDT, Apr 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

47 48 Next >

DexCom Inc (NASDAQ:DXCM) Fits the Affordable Growth Investment Strategy ↗

Today 7:01 EDT

DexCom (DXCM) exemplifies GARP investing, offering strong growth in glucose monitoring at a price reasonable relative to its industry and supported by robust profitability.

Via Chartmill

DexCom (DXCM) Q2 2025 Earnings Call Transcript ↗

April 08, 2026

DexCom (DXCM) Q2 2025 Earnings Call Transcript

Via The Motley Fool

Topics Artificial Intelligence Earnings

DexCom (DXCM) Q3 2025 Earnings Call Transcript ↗

April 08, 2026

DexCom (DXCM) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

DexCom Inc (NASDAQ:DXCM) Presents a Growth Stock Breakout Opportunity ↗

March 25, 2026

Via Chartmill

DexCom Inc (NASDAQ:DXCM): A Prime Example of Growth at a Reasonable Price ↗

March 10, 2026

Via Chartmill

Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring

April 02, 2026

Shares of Eli Lilly and Company (NYSE: LLY) surged 3.8% on Wednesday following the milestone FDA approval of Foundayo (orforglipron), the first once-daily oral weight-loss pill that does not require...

Via MarketMinute

Topics Economy

Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time

April 02, 2026

From DexCom, Inc.

Via Business Wire

The Medtronic Transformation: A Deep Dive into the Future of a MedTech Titan

April 01, 2026

As of April 1, 2026, the global medical technology landscape is undergoing a profound shift, and at the center of this evolution is Medtronic plc (NYSE: MDT). Long regarded as the "sleeping giant" of...

Via Finterra

Topics Artificial Intelligence Economy Initial Public Offering

2 Growth Stocks with All-Star Potential and 1 That Underwhelm

April 01, 2026

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived thr...

Via StockStory

Topics Artificial Intelligence

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

Via StockStory

Topics Artificial Intelligence Government Stocks

Stay informed with the top movers within the S&P500 index on Friday. ↗

March 27, 2026

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

March 27, 2026

Via Chartmill

2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Headwinds

March 27, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...

Via StockStory

2 Healthcare Stocks to Target This Week and 1 That Underwhelm

March 23, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme...

Via StockStory

Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know

March 16, 2026

What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. ...

Via StockStory

Topics Economy Stocks

This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment ↗

March 15, 2026

EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships.

Via The Motley Fool

This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement ↗

March 15, 2026

This medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide.

Via The Motley Fool

Topics Regulatory Compliance

This Internet Infrastructure Stock Plunged 72% in a Year, so Why Did an Investor Buy Up $12 Million? ↗

March 15, 2026

Cogent Communications delivers high-speed internet and data center services to commercial clients across multiple continents.

Via The Motley Fool

Topics Regulatory Compliance

Sotera Health Shares Rise 18% in a Year. Here's What a $37 Million Stake Trim Signals ↗

March 15, 2026

Sotera Health delivers sterilization and lab testing services to regulated industries worldwide, supporting critical supply chains.

Via The Motley Fool

Topics Regulatory Compliance

Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

March 11, 2026

From DexCom, Inc.

Via Business Wire

2 Growth Stocks to Hold for the Next Decade ↗

March 10, 2026

They are down, but they are not out.

Via The Motley Fool

Topics World Trade

Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know

March 06, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

Via StockStory

Topics Economy

Which S&P500 stocks are gapping on Wednesday? ↗

March 04, 2026

Via Chartmill

1 Nasdaq 100 Stock with Impressive Fundamentals and 2 We Avoid

March 03, 2026

While the Nasdaq 100 (^NDX) is filled with cutting-edge technology and consumer companies, not all are on solid footing. Some are dealing with declining demand, high costs, or regulatory pressures that...

Via StockStory

Dexcom Appoints Rick Osterloh to Board of Directors

February 26, 2026

From DexCom, Inc.

Via Business Wire

Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars ↗

February 25, 2026

It's another reason to invest in this exciting medical device stock.

Via The Motley Fool

Dexcom Announces Upcoming Conference Presentation

February 25, 2026

From DexCom, Inc.

Via Business Wire

The Great Unlocking: Medtronic’s Strategic Pivot and the MiniMed Spin-Off

February 24, 2026

Date: February 24, 2026 By: Financial Research Analyst Introduction For years, Medtronic plc (NYSE: MDT) was viewed by Wall Street as a reliable but sluggish giant—a "Dividend Aristocrat" that offered...

Via Finterra

Topics Artificial Intelligence Economy Initial Public Offering

The 5 Most Interesting Analyst Questions From DexCom’s Q4 Earnings Call

February 19, 2026

DexCom’s fourth quarter results reflected ongoing momentum in both product innovation and international expansion. Management attributed the quarter’s performance to the broad rollout of the G7 15-day...

Via StockStory

Topics Earnings

Insulet (PODD) Shakes the Market with Q4 Earnings Beat as Omnipod 5 Dominance Continues

February 18, 2026

Insulet Corporation (NASDAQ:PODD) delivered a commanding performance in its fourth-quarter earnings report released today, February 18, 2026. The medical device leader announced an adjusted earnings...

Via MarketMinute

Topics Earnings

< Previous 1 2 3 4 5 6 7 8 9

...

47 48 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.